Unsere News
14.06.2022
When Distancing Rules are Futile
Researchers from ETH Zurich and the Swiss Tropical and Public Health Institute (Swiss TPH) have created a risk map showing which regions in Africa may see a faster spread of... More...
18.05.2022
Swiss TPH Awarded Four New Research Grants in Paediatric Health
Swiss TPH has been awarded four out of six new research grants from the Principal Investigator Initiative of the Botnar Research Centre for Child Health (BRCCH). The initiative... More...
02.05.2022
Legionellosis Cases Continue to Increase in Switzerland
The number of legionellosis cases in Switzerland has increased five-fold over the past 20 years. A study by the Swiss Tropical and Public Health Institute (Swiss TPH) published... More...
01.04.2022
New Swiss TPH Headquarters Opened in Allschwil
On Friday, 1 April 2022, the new headquarters of the Swiss Tropical and Public Health Institute (Swiss TPH) officially opened in the BaseLink site, an emerging life science cluster... More...
16.03.2022
Increasing Awareness of Noma – A Severe but Treatable Disease
There is very limited data on the incidence and prevalence of noma, which hinders better management and treatment of this devastating disease that mainly affects young and... More...
25.02.2022
Gut Microbiota Influences Treatment against Parasitic Worms
Almost a quarter of the world's population is at risk of helminth infections and available treatment options are limited. Therefore, a better understanding of why anti-parasitic... More...
16.02.2022
Farewell to Dr. Mwele Ntuli Malecela, Director of the Department of Control of Neglected Tropical Diseases at WHO
It is with great sadness that we learned about the passing of Dr. Mwele Ntuli Malecela, Director of Neglected Tropical Diseases at the World Health Organization (WHO). We have lost... More...
11.02.2022
Multi-Insecticide Resistant Malaria Vectors Remain Susceptible to Malathion Insecticide
Insecticide resistant mosquitoes are a growing concern in malaria control. A study conducted by Swiss TPH and partners raises hope that multi-resistant malaria vectors remain... More...
10.02.2022
ANTICOV: Clinical Trial for COVID-19 in Low-resource Settings to Test a New Drug Combination
The need for effective COVID-19 treatments remains particularly acute, especially in sub-Saharan Africa where access to vaccines is still extremely limited. The ANTICOV clinical... More...